Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Routine delivery of myoblasts during coronary artery bypass surgery: why not?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages S90–S93 (2006)Cite this article

Abstract

Skeletal myoblast transplantation has now entered the clinical arena as a potential means of restoring function to scarred myocardium. While the current experience derived from phase I trials suggests that cell implantation during coronary artery bypass operations is a straightforward and safe procedure, routine use of myoblast transplantation would certainly be premature. Two major issues have not yet been addressed: firstly, the risk–benefit ratio needs to be assessed, specifically whether the potential proarrhythmic risk associated with myoblast transplantation is supported by the results of an ongoing large, randomized study, and if so, whether this risk is offset by a benefit in terms of improvement of left ventricular function and patient outcome. Secondly, this putative benefit will then have to be weighed against the financial burden inherent to this type of procedure, to assess whether the cost–effectiveness ratio is favorably shifted and supports the expanded indication of myoblast transplantation during coronary artery revascularization in patients with severe ischemic heart failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Dowell J et al. (2003) Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58: 336–350

    Article  CAS  Google Scholar 

  2. Menasche P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078–1083

    Article  Google Scholar 

  3. Herreros J et al. (2003) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24: 2012–2020

    Article  Google Scholar 

  4. Siminiak T et al. (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148: 531–537

    Article  Google Scholar 

  5. Dib N et al. (2005) Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: interim analysis from the United States experience. Circulation 112: 1743–1747

    Article  Google Scholar 

  6. Hagège AA et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491–492

    Article  Google Scholar 

  7. Pagani F et al. (2003) Autologous skeletal myoblasts transplanted to ischemia damaged myocardium in humans. J Am Coll Cardiol 41: 879–888

    Article  Google Scholar 

  8. Leobon B et al. (2003) Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 100: 7808–7811

    Article  CAS  Google Scholar 

  9. Rubart M et al. (2004) Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114: 775–783

    Article  CAS  Google Scholar 

  10. Bigger JT (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337: 1569–1575

    Article  Google Scholar 

  11. Tambara K et al. (2003) Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108 (Suppl I): 259–263

    Google Scholar 

  12. Curtis AB et al. (1998) Epicardial cardioverter-defibrillators do not cause postoperative arrhythmia. The CABG Patch Trial Investigators. Coronary Artery Bypass Graft. Am J Cardiol 82: 1114–1117

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Surgery, University Paris-Descartes, Faculté de Médecine, and Staff Cardiac Surgeon, Hôpital Européen Georges Pompidou,

    Philippe Menasché

  2. Staff Cardiologists in the Department of Cardiology at the Hôpital Européen Georges Pompidou, University Paris-Descartes, Faculté de Médecine,

    Michel Desnos & Albert A Hagège

  3. all three are in INSERM U 633, Paris, France

    Philippe Menasché, Michel Desnos & Albert A Hagège

Authors
  1. Philippe Menasché
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Desnos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albert A Hagège
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Menasché.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Menasché, P., Desnos, M. & Hagège, A. Routine delivery of myoblasts during coronary artery bypass surgery: why not?. Nat Rev Cardiol 3 (Suppl 1), S90–S93 (2006). https://doi.org/10.1038/ncpcardio0406

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0406

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing